These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

20 related articles for article (PubMed ID: 1932573)

  • 1. Folded conformations of antigenic peptides from riboflavin carrier protein in aqueous hexafluoroacetone.
    Bhattacharjya S; Awasthi SK; Adiga PR; Balaram P
    Protein Sci; 1998 Jan; 7(1):123-31. PubMed ID: 9514267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of the epitopes of calcitonin gene-related peptide (CGRP) for two anti-CGRP monoclonal antibodies by 2D NMR.
    Hubbard JA; Raleigh DP; Bonnerjea JR; Dobson CM
    Protein Sci; 1997 Sep; 6(9):1945-52. PubMed ID: 9300494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The tyrosine phosphorylation site of the acetylcholine receptor beta subunit is located in a highly immunogenic epitope implicated in channel function: antibody probes for beta subunit phosphorylation and function.
    Tzartos SJ; Valcana C; Kouvatsou R; Kokla A
    EMBO J; 1993 Dec; 12(13):5141-9. PubMed ID: 7505221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The main immunogenic region (MIR) of the nicotinic acetylcholine receptor and the anti-MIR antibodies.
    Tzartos SJ; Cung MT; Demange P; Loutrari H; Mamalaki A; Marraud M; Papadouli I; Sakarellos C; Tsikaris V
    Mol Neurobiol; 1991; 5(1):1-29. PubMed ID: 1725702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclic lactam analogues containing the main immunogenic region of Torpedo acetylcholine receptor.
    Detsikas E; Tsikaris V; Sakarellos-Daitsiotis M; Sakarellos C; Cung MT; Marraud M; Vatzaki E; Tzartos SJ
    Pept Res; 1993; 6(1):17-23. PubMed ID: 7679937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conformational requirements for molecular recognition of acetylcholine receptor main immunogenic region (MIR) analogues by monoclonal anti-MIR antibody: a two-dimensional nuclear magnetic resonance and molecular dynamics approach.
    Tsikaris V; Detsikas E; Sakarellos-Daitsiotis M; Sakarellos C; Vatzaki E; Tzartos SJ; Marraud M; Cung MT
    Biopolymers; 1993 Jul; 33(7):1123-34. PubMed ID: 8343589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two-dimensional 1H-NMR study of synthetic peptides containing the main immunogenic region of the Torpedo acetylcholine receptor.
    Cung MT; Marraud M; Hadjidakis I; Bairaktari E; Sakarellos C; Kokla A; Tzartos S
    Biopolymers; 1989 Jan; 28(1):465-78. PubMed ID: 2470436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The third-dimensional structure of the complex between an Fv antibody fragment and an analogue of the main immunogenic region of the acetylcholine receptor: a combined two-dimensional NMR, homology, and molecular modeling approach.
    Kleinjung J; Petit MC; Orlewski P; Mamalaki A; Tzartos SJ; Tsikaris V; Sakarellos-Daitsiotis M; Sakarellos C; Marraud M; Cung MT
    Biopolymers; 2000 Feb; 53(2):113-28. PubMed ID: 10679615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The main immunogenic region of the nicotinic acetylcholine receptor. Identification of amino acid residues interacting with different antibodies.
    Bellone M; Tang F; Milius R; Conti-Tronconi BM
    J Immunol; 1989 Dec; 143(11):3568-79. PubMed ID: 2584708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On the initial trigger of myasthenia gravis and suppression of the disease by antibodies against the MHC peptide region involved in the presentation of a pathogenic T-cell epitope.
    Atassi MZ; Oshima M; Deitiker P
    Crit Rev Immunol; 2001; 21(1-3):1-27. PubMed ID: 11642597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two-dimensional 1H-NMR study of antigen-antibody interactions: binding of synthetic decapeptides to an anti-acetylcholine receptor monoclonal antibody.
    Cung MT; Demange P; Marraud M; Tsikaris V; Sakarellos C; Papadouli I; Kokla A; Tzartos SJ
    Biopolymers; 1991 May; 31(6):769-76. PubMed ID: 1932573
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 1.